Focused Wealth Management’s Albany Molecular Research Inc AMRI Stock Holding History

Focused Wealth Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-340	Closed	-$5K	–	753
2016 Q1	$5K	Hold	340	–	–	﹤0.01%	492
2015 Q4	$7K	Hold	340	–	–	﹤0.01%	471
2015 Q3	$6K	Hold	340	–	–	﹤0.01%	482
2015 Q2	$7K	Hold	340	–	–	﹤0.01%	469
2015 Q1	$6K	Hold	340	–	–	﹤0.01%	517
2014 Q4	$6K	Hold	340	–	–	﹤0.01%	502
2014 Q3	$8K	Hold	340	–	–	0.01%	463
2014 Q2	$7K	Hold	340	–	–	0.01%	479
2014 Q1	$6K	Sell	340 -180	-35%	-$2.48K	0.01%	472
2013 Q4	$5K	Buy	+520	New	+$6.28K	﹤0.01%	491

Other funds holding AMRI

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Focused Wealth Management's AMRI Position: Q2 2016 in Review

Focused Wealth Management sold out of Albany Molecular Research Inc (AMRI) in Q2 2016, closing a stake of 340 shares — an estimated $5K sold.

Focused Wealth Management first reported a position in AMRI in Q4 2013 and held it in 10 quarters. The position peaked at $8K in Q3 2014. 142 funds tracked by Wall St. Rank hold AMRI as of Q2 2016.

Focused Wealth Management reported no remaining Albany Molecular Research Inc position as of Q2 2016 after selling out during the quarter.
Focused Wealth Management sold 340 Albany Molecular Research Inc shares in Q2 2016, an estimated $5K.
Focused Wealth Management first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 10 quarters.
Focused Wealth Management's Albany Molecular Research Inc position peaked at $8K in Q3 2014.
142 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2016.

Based on Focused Wealth Management's 13F filing for Q2 2016, filed 10 Aug 2016.